Aceso Life Science Group Limited (0474.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 698.02M |
| Enterprise Value | 1.74B |
| P/E Ratio | 3 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 19.65 |
| Price/Book Ratio | 2.76 |
| Enterprise/Revenue | 35.94 |
| Enterprise/EBITDA | -2.96 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 5.28 |
| Operating Margin | 0.63 |
AD
Management Effectiveness
| Return On Assets | 0.19 |
| Return On Equity | 0.82 |
Income Statement
| Revenue | 64M |
| Revenue/Share | 0.01 |
| Gross Profit | 54M |
| EBITDA | -297M |
| Net Income | 338M |
| Diluted EPS | -0.06 |
Balance Sheet
| Total Cash | 345M |
| Total Cash/Share | 0.04 |
| Total Debt | 1.19B |
| Total Debt/Equity | 2.6 |
| Current Ratio | 5.52 |
| Book Value Per Share | 0.05 |
Price History
| 52-Week Change | 102.86 |
| 52-Week High | 0.16 |
| 52-Week Low | 0.06 |
| Moving Average 50 Days | 0.14 |
| Moving Average 200 Days | 0.12 |
Statistics
| Average Volume | 2.51M |
| Shares Outstanding | 8.86B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 7:6 |
| Last Split Date | July 12, 2017 |
AD
